Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00454207Phase 3Completed
A Phase 3 trial of sildenafil in pulmonary arterial hypertension (PAH), sponsored by Viatris. Started Apr 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00454207.